Insight into eukaryotic topoisomerase II-inhibiting fused heterocyclic compounds in human cancer cell lines by molecular docking

By Taskin T.   Yilmaz S.   Yildiz I.   Yalcin I.   Aki E.  

SAR and QSAR in Environmental Research, Vol. 23, Iss. 3-4, 2012-04 ,pp. : 345-355

Taylor & Francis Ltd

Access to resources Recommend Favorite

Synthesis, Biological Evaluation and Molecular Docking Studies of Ferrocene Derivatives Coupling with N-heterocyclic on Human Breast Cancer

By  

MATEC Web of conference, Vol. 22, Iss. issue, 2015-07 ,pp. : 05001-05001

Edp Sciences

Access to resources Recommend Favorite

Evaluation of rat hepatic 2E1 activity in function of age, sex and inducers: choice of an experimental model capable of testing the hepatotoxicity of low molecular weight compounds

By Morel G.   Cossec B.   Lambert A.M.   Binet S.  

Toxicology Letters, Vol. 106, Iss. 2, 1999-06 ,pp. : 171-180

Elsevier

Access to resources Recommend Favorite

Assessment of Preferential Th1 or Th2 Induction by Low-Molecular-Weight Compounds Using a Reverse Transcription-Polymerase Chain Reaction Method: Comparison of Two Mouse Strains, C57BL/6 and Balb/c

By Hayashi M.   Higashi K.   Kato H.   Kaneko H.  

Toxicology and Applied Pharmacology, Vol. 177, Iss. 1, 2001-11 ,pp. : 38-45

Elsevier

Access to resources Recommend Favorite

Assessment of Preferential T-Helper 1 or T-Helper 2 Induction by Low Molecular Weight Compounds Using the Local Lymph Node Assay in Conjunction with RT-PCR and ELISA for Interferon- and Interleukin-4

By Vandebriel R.J.   De Jong W.H.   Spiekstra S.W.   Van Dijk M.   Fluitman A.   Garssen J.   Van Loveren H.  

Toxicology and Applied Pharmacology, Vol. 162, Iss. 2, 2000-01 ,pp. : 77-85

Elsevier

Access to resources Recommend Favorite